287 related articles for article (PubMed ID: 25341473)
1. Estimated prevalence and incidence of multiple sclerosis in Iran.
Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
[TBL] [Abstract][Full Text] [Related]
2. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
3. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.
Sahraian MA; Khorramnia S; Ebrahim MM; Moinfar Z; Lotfi J; Pakdaman H
Eur Neurol; 2010; 64(6):331-6. PubMed ID: 21071949
[TBL] [Abstract][Full Text] [Related]
5. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Maghzi AH; Ghazavi H; Ahsan M; Etemadifar M; Mousavi S; Khorvash F; Minagar A
Mult Scler; 2010 Mar; 16(3):359-61. PubMed ID: 20086021
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
7. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
8. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
[TBL] [Abstract][Full Text] [Related]
9. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of Iran.
Molazadeh N; Mohebi F; Altafi D; Sahraian MA
Mult Scler Relat Disord; 2021 Jan; 47():102605. PubMed ID: 33217696
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Multiple Sclerosis in Torbat-e Heydarieh (Northeast of Iran) during 1982-2016.
Moghaddam VK; Sarmadi M; Tatari M; Najafi F; Esmaeili A; Hadei M
Mult Scler Relat Disord; 2018 Aug; 24():184-189. PubMed ID: 30077941
[TBL] [Abstract][Full Text] [Related]
13. Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?
Pakdel M; Karin Hedström A; Bidkhori M; Hadei M; Kazemi Moghaddam V; Sarmadi M; Zohdi S; Marufi N
Acta Neurol Scand; 2019 Nov; 140(5):328-335. PubMed ID: 31291697
[TBL] [Abstract][Full Text] [Related]
14. Geographic variations of multiple sclerosis in Iran: A population based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Mult Scler Relat Disord; 2019 Feb; 28():244-249. PubMed ID: 30634104
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis among Afghan immigrants in Isfahan, Iran.
Etemadifar M; Sadeghpour N; Nekouie K; Jahansouz M; Salari M; Fereidan-Esfahani M
Mult Scler Relat Disord; 2017 Apr; 13():52-57. PubMed ID: 28427703
[TBL] [Abstract][Full Text] [Related]
16. Incidence of multiple sclerosis in Iran: a nationwide, population-based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Public Health; 2019 Oct; 175():138-144. PubMed ID: 31476710
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of multiple sclerosis in Iran: a systematic review.
Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
[TBL] [Abstract][Full Text] [Related]
18. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
[TBL] [Abstract][Full Text] [Related]
19. The trend of incidence, prevalence, and DALY of multiple sclerosis in the Middle East and Northern Africa region compared to global, West Europe and, Iran's corresponding values during 1990-2017: Retrieved from global burden of diseases data.
Abbastabar H; Bitarafan S; Mohammadpour Z; Mohammadianinejad SE; Harirchian MH
Mult Scler Relat Disord; 2021 Jul; 52():102949. PubMed ID: 33894481
[TBL] [Abstract][Full Text] [Related]
20. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]